This is a recording of the presentation by Christian Schnell from Novartis Oncology on addressing the challenges of enabling the translation of tumor models in cancer therapy by using secreted luciferases to monitor tumor metastasis. The presentation was part of our Swiss 3Rs Day 2024, focused on oncology, held at the AGORA Cancer Research Centre in Lausanne. Click here to access the event summary.